Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.
Mol Psychiatry July 28, 2026 DOI: 10.1038/s41380-026-03777-z (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Esketamine Ketamine |
| Key points | Argues that ketamine and psychedelics share a convergent neuroimmune signaling mechanism that underlies their rapid antidepressant effects, proposing that modulation of neuroimmune pathways is a key therapeutic target. |
Abstract
Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.